Association between intrauterine fetal growth restriction and ABO blood groups at King Abdulaziz University Hospital, Saudi Arabia: Retrospective study

Article Figures & Data

Table 1

- Nationality and comorbidities among the patients (study group).

Table 2

- Past and current pregnancy-related complications

Comorbidities	n	%
Past history
Gestational diabetes mellitus	37	9.0
Pregnancy induced hypertension	13	3.1
Preeclampsia	14	3.4
Hemorrhage during pregnancy	6	1.5
Ectopic pregnancy	6	1.4
Abortion	29	6.7
Preterm labor	16	3.9
History of congenital anomaly	5	1.2
Current pregnancy
Gestational diabetes mellitus	59	13.9
Pregnancy induced hypertension	15	3.4
Eclampsia	3	0.7
Antepartum hemorrhage	6	1.4

Table 3

- Showing maternal, neonatal, and delivery-related findings.

Maternal and neonatal outcome	n	%
Mode of delivery
Vaginal delivery	247	56.7
Assisted vaginal delivery	17	3.9
Total cesarean section	172	39.4
Elective cesarean section	82	18.8
Emergency cesarean section	90	20.6
Analgesia/anesthesia type
Inhaler	114	26.1
Regional	301	69.0
General	21	4.8
Baby gender
Male	209	47.9
Female	227	52.1
Resuscitation
C-PAP	1	0.2
PPV & suction	10	2.3
C-PAP & PPV	2	0.5
PPV & intubation	1	0.2
C-PAP + PPV + intubation	1	0.2
Neonatal outcome
Live birth	433	99.3
Intrauterine fetal death	3	0.7
Neonatal complication
No complications	425	97.5
Neonatal intensive care unit admission	7	1.6
Neonatal death	3	0.7
IUGR
Yes	112	25.7
No	324	74.3
C-PAP: continuous positive airway pressure, PPV: positive pressure ventilation, IUGR: ntrauterine fetal growth restriction

Table 4

- The distribution of intrauterine growth restriction (IUGR) rate across ABO blood groups and rhesus antibodies

	IUGR	Normal	P-value
Blood group
A	33 (26.6)	91 (73.4)	0.826
B	20 (27.8)	52 (72.2)
AB	6 (31.6)	13 (68.4)
O	53 (24)	168 (76)
Rhesus
Positive	106 (25.7)	307 (74.3)	0.964
Negative	6 (26.1)	17 (73.9)	0.964
Values are presented as numbers and percentages (%). The significance level p-value at 0.05.